TickerFactsScreenerDevelopers

Enliven Therapeutics, Inc. (ELVN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2018: -$26.32M2019: -$48.85M2020: $84.44M2021: -$42.89M2022: -$76.83M2023: $245.91M2024: $309.85M2025: $459.60M$459.60M
2018Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$459.60M+48.3%
2024$309.85M+26.0%
2023$245.91M+420.1%
2022-$76.83M-79.1%
2021-$42.89M-150.8%
2020$84.44M+272.9%
2019-$48.85M-85.6%
2018-$26.32M—